Last Name


Search Results to Robin Jones

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Jones, Robin

Item TypeName
Concept Kaplan-Meier Estimate
Academic Article Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
Academic Article Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.
Academic Article The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
Academic Article PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study.
Academic Article Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.
Academic Article PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.
Academic Article Chemotherapy in clear cell sarcoma.
Academic Article Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma.
Academic Article Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Academic Article Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
Academic Article Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.
Academic Article Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas.
Academic Article Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
Academic Article Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Academic Article Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma.
Academic Article Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.

Search Criteria
  • Kaplan
  • Meier
  • Estimate